EDGAR Filing Documents for 0001558370-21-001797

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-21-001797

Filing Date

2021-02-25

Accepted

2021-02-25 16:01:49

Documents

113

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	kala-20201231x10k.htm iXBRL	10-K	2631417
2	EX-4.2	kala-20201231xex4d2.htm	EX-4.2	426809
3	EX-10.26	kala-20201231xex10d26.htm	EX-10.26	43443
4	EX-10.31	kala-20201231xex10d31.htm	EX-10.31	18296
5	EX-21.1	kala-20201231xex21d1.htm	EX-21.1	4572
6	EX-23.1	kala-20201231xex23d1.htm	EX-23.1	2400
7	EX-31.1	kala-20201231xex31d1.htm	EX-31.1	8982
8	EX-31.2	kala-20201231xex31d2.htm	EX-31.2	8939
9	EX-32.1	kala-20201231xex32d1.htm	EX-32.1	5103
10	EX-32.2	kala-20201231xex32d2.htm	EX-32.2	5997
11	GRAPHIC	kala-20201231xex10d26001.jpg	GRAPHIC	3720
12	GRAPHIC	kala-20201231x10k006.jpg	GRAPHIC	65401
13	GRAPHIC	kala-20201231x10k007.jpg	GRAPHIC	41495
14	GRAPHIC	kala-20201231x10k009.jpg	GRAPHIC	61444
15	GRAPHIC	kala-20201231x10k011.jpg	GRAPHIC	25610
16	GRAPHIC	kala-20201231x10k012.jpg	GRAPHIC	21931
17	GRAPHIC	kala-20201231x10k013.jpg	GRAPHIC	45476
18	GRAPHIC	kala-20201231x10k014.jpg	GRAPHIC	38671
	Complete submission text file	0001558370-21-001797.txt		11278769

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	kala-20201231.xsd	EX-101.SCH	70973
20	EX-101.CAL	kala-20201231_cal.xml	EX-101.CAL	73047
21	EX-101.DEF	kala-20201231_def.xml	EX-101.DEF	261050
22	EX-101.LAB	kala-20201231_lab.xml	EX-101.LAB	638889
23	EX-101.PRE	kala-20201231_pre.xml	EX-101.PRE	507631
24	EXTRACTED XBRL INSTANCE DOCUMENT	kala-20201231x10k_htm.xml	XML	1608083

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472

Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252

Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)